Alteplase for acute ischemic stroke: 2 years in a community hospital without previous experience in stroke thrombolysis

Intravenous administration of recombinant tissue plasminogen activator (rt-PA) remains the most beneficial proven intervention for emergency treatment of stroke. The objective of the present study was to assess the implementation of the 'Stroke code' in routine clinical care at our center in the last 2 years and to describe the clinical outcome of patients who received treatment with intravenous rt-PA.